These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Exclusion of elderly people from clinical research: a descriptive study of published reports. Bugeja G; Kumar A; Banerjee AK BMJ; 1997 Oct; 315(7115):1059. PubMed ID: 9366735 [No Abstract] [Full Text] [Related]
63. Minimization, by its nature, precludes allocation concealment, and invites selection bias. Berger VW Contemp Clin Trials; 2010 Sep; 31(5):406. PubMed ID: 20457277 [No Abstract] [Full Text] [Related]
64. Including elderly people in clinical trials. Avorn J BMJ; 1997 Oct; 315(7115):1033-4. PubMed ID: 9366725 [No Abstract] [Full Text] [Related]
66. [Which factors influence inclusion of thoracic cancer patients in clinical trials?]. Lozano S; Leseux L; Mazieres J Rev Mal Respir; 2015 May; 32(5):544-6. PubMed ID: 25498768 [No Abstract] [Full Text] [Related]
67. Commentary: "Leaning in" to support sex differences in basic science and clinical research. Woodruff TK; Kibbe MR; Paller AS; Turek FW; Woolley CS Endocrinology; 2014 Apr; 155(4):1181-3. PubMed ID: 24506076 [No Abstract] [Full Text] [Related]
68. Is clinical research still too haphazard? Clark O; Clark L; Djulbegovic B Lancet; 2001 Nov; 358(9293):1648. PubMed ID: 11716926 [No Abstract] [Full Text] [Related]
69. The exclusion of older people from participation in cardiovascular trials. Gurwitz JH Virtual Mentor; 2014 May; 16(5):365-8. PubMed ID: 24847706 [No Abstract] [Full Text] [Related]
70. Too many hidden patients. The exclusion of individuals with Alzheimer's disease from Alzheimer's disease pharmacological clinical trials. Almici M; Sartori S; Lombardi F; Bonomini C; Geroldi C; Zanetti O J Am Geriatr Soc; 2012 Aug; 60(8):1596-7. PubMed ID: 22889034 [No Abstract] [Full Text] [Related]
71. [Not Available]. Kiefer B Rev Med Suisse; 2016 Aug; 12(527):1400. PubMed ID: 28671800 [No Abstract] [Full Text] [Related]
72. The under-representation of older people in clinical trials: barriers and potential solutions. Habicht DW; Witham MD; McMurdo ME J Nutr Health Aging; 2008 Mar; 12(3):194-6. PubMed ID: 18309441 [TBL] [Abstract][Full Text] [Related]
73. Lost in translation: bumps in the road between bench and bedside. Levin LA; Danesh-Meyer HV JAMA; 2010 Apr; 303(15):1533-4. PubMed ID: 20407063 [No Abstract] [Full Text] [Related]
74. Increasing enrollment in drug trials: the need for greater transparency about the social value of research in recruitment efforts. Yarborough MA Mayo Clin Proc; 2013 May; 88(5):442-5. PubMed ID: 23639497 [No Abstract] [Full Text] [Related]
75. Why should patients participate in research? Natland S; Tveiten S; Knutsen IR Tidsskr Nor Laegeforen; 2017 Feb; 137(3):210-212. PubMed ID: 28181760 [No Abstract] [Full Text] [Related]
76. Individual patients are the primary source and the target of clinical research. Knottnerus JA; Tugwell P; Tricco AC J Clin Epidemiol; 2016 Aug; 76():1-3. PubMed ID: 27670675 [No Abstract] [Full Text] [Related]
77. Patients in research: not just subjects, but partners. Heymann SJ Science; 1995 Aug; 269(5225):797-8. PubMed ID: 7638595 [No Abstract] [Full Text] [Related]
78. Clinical trials in elderly patients. Jackson SH Ernst Schering Res Found Workshop; 2007; (59):101-9. PubMed ID: 17117717 [TBL] [Abstract][Full Text] [Related]
79. Attention to fidelity: why is it important. Breitenstein S; Robbins L; Cowell JM J Sch Nurs; 2012 Dec; 28(6):407-8. PubMed ID: 23132849 [No Abstract] [Full Text] [Related]
80. Taking a stand against the politicization of medical research: how 'swinging the pendulum' poses a hazard to clinical trials, study participants, and the progress of science. Bershteyn A; Schwartz MD; Thorpe LE; Paasche-Orlow MK; Kissinger P; Stankiewicz Karita HC; Laufer MK; Hoffman RM; Landovitz RJ; Paolino K; Barnabas RV Expert Rev Clin Immunol; 2021 Jan; 17(1):101-103. PubMed ID: 33284056 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]